MGMT and glioblastoma: IDH1 mutations are rare in primary GBM cases.7 In comparison, the prognosis value of MGMT promoter might depend on the chemotherapeutic substances used 6 and might lose the value under some conditions.8, 9 Therefore, it is quite meaningful to further explore other potential prognostic markers in GBM.